Susan Domchek: Difference between revisions
m Moving from Category:Women oncologists to Category:American women oncologists using Cat-a-lot |
Remove copyright infringement from https://www.med.upenn.edu/endowedprofessorships/basser-professorship-in-oncology.html. Do NOT restore. |
||
Line 1: | Line 1: | ||
{{short description|American oncologist}} |
{{short description|American oncologist}} |
||
⚫ | '''Susan M. Domchek''' is an [[Oncology|oncologist]] at the [[University of Pennsylvania]], Executive Director of the Basser Center for BRCA, the Basser Professor in Oncology at the [[Perelman School of Medicine at the University of Pennsylvania|Perelman School of Medicine]], and Director of the Mariann and Robert MacDonald Cancer Risk Evaluation Program at [[University of Pennsylvania Health System|Penn Medicine]].<ref name="NYT">{{Cite news|url=https://www.nytimes.com/2018/03/06/well/fda-brca-home-testing.html|title=F.D.A. Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats|last=Rabin|first=Roni Caryn|date=2018-03-06|work=The New York Times|access-date=2019-04-05|language=en-US|issn=0362-4331}}</ref><ref>{{Cite web|title=Home {{!}} Basser Center|url=https://www.basser.org/|access-date=2021-08-24|website=www.basser.org}}</ref> She has authored more than 250 articles in scholarly journals. In 2018, Domchek was elected to the [[National Academy of Medicine]]. |
||
{{Close paraphrasing|source=https://www.facingourrisk.org/about-ust/our-impact/media-center/assets/Spirit-of-Empowerment-2018-Press-Release.pdf|date=July 2019}} |
|||
⚫ | '''Susan M. Domchek''' is an [[Oncology|oncologist]] at the [[University of Pennsylvania]], Executive Director of the Basser Center for BRCA, the Basser Professor in Oncology at the [[Perelman School of Medicine at the University of Pennsylvania|Perelman School of Medicine]], and Director of the Mariann and Robert MacDonald Cancer Risk Evaluation Program at [[University of Pennsylvania Health System|Penn Medicine]].<ref name="NYT">{{Cite news|url=https://www.nytimes.com/2018/03/06/well/fda-brca-home-testing.html|title=F.D.A. Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats|last=Rabin|first=Roni Caryn|date=2018-03-06|work=The New York Times|access-date=2019-04-05|language=en-US|issn=0362-4331}}</ref><ref>{{Cite web|title=Home {{!}} Basser Center|url=https://www.basser.org/|access-date=2021-08-24|website=www.basser.org}}</ref> She has authored more than 250 articles in scholarly journals |
||
==Career== |
==Career== |
||
In 2011, she led the organization of the international team of physician scientists known as BRCA-TAC, which led a charge to advance clinical testing of [[olaparib]] in cancer patients with known inherited mutations in [[BRCA1]] and [[BRCA2]].<ref name="FORCE">{{Cite web|last=|first=|date=|title=FORCE Announces 2018 Spirit of Empowerment Awards Recipients|url=https://www.facingourrisk.org/about-ust/our-impact/media-center/assets/Spirit-of-Empowerment-2018-Press-Release.pdf|access-date=|website=Facing Our Risk of Cancer Empowered}}</ref><ref name="NYT" /> Cancers that are associated with ''BRCA1'' and ''BRCA2'' include breast cancer in men and women, ovarian cancer, [[melanoma]], [[Prostate cancer|prostate]] and [[Pancreatic cancer|pancreatic]] cancer.<ref>{{Cite web|last=Mackin-Solomon|first=Ashley|date=2018-07-26|title=Panel on BRCA genes in La Jolla explains cancer risks|url=https://www.lajollalight.com/news/health-science/sd-lawrence-family-jcc-hosts-brca-forum-20180724-story.html|access-date=2019-04-05|website=lajollalight.com|language=en-US}}</ref> |
|||
In 2012, Domchek was named Executive Director of the Basser Center for BRCA at Penn Medicine's Abramson Cancer Center |
In 2012, Domchek was named Executive Director of the Basser Center for BRCA at Penn Medicine's Abramson Cancer Center.<ref>{{Cite web|title=About the Basser Center {{!}} Basser Center|url=https://www.basser.org/about-us|access-date=2021-08-24|website=www.basser.org}}</ref> In 2015, Domchek was awarded the William Osler Patient Oriented Research Award for her clinical research in breast cancer genetics.<ref>{{cite web |title=2015 Perelman School of Medicine Awards of Excellence |url=https://almanac.upenn.edu/articles/2015-perelman-school-of-medicine-awards-of-excellence |website=almanac.upenn.edu |accessdate=April 5, 2019 |date=November 17, 2015}}</ref> In 2018, Domchek was elected to the [[National Academy of Medicine]]<ref>{{cite web|date=October 15, 2018|title=Four Penn Faculty Members Elected to National Academy of Medicine|url=https://www.pennmedicine.org/news/news-releases/2018/october/four-penn-faculty-members-elected-to-national-academy-of-medicine|website=pennmedicine.org|accessdate=April 5, 2019}}</ref> and was honored with the 2018 Spirit of Empowerment by the non-profit organization Facing Our Risk of Cancer Empowered.<ref name="FORCE" /> |
||
Domchek is a significant contributor to the oncology literature and has authored/co-authored more than 350 articles appearing in scholarly journals including the [[The New England Journal of Medicine|New England Journal of Medicine]], the [[Journal of the American Medical Association]], and the [[Journal of Clinical Oncology]]. An elected member of the [[National Academy of Medicine]], the American Society of Clinical Investigation, and the [[Association of American Physicians]], Dr. Domchek is also a Fellow of the [[American Society of Clinical Oncology]] (FASCO), a recognition bestowed upon ASCO members who have shown extraordinary dedication for their voluntary efforts that benefit the Society, the specialty of oncology, and most importantly to her patients.<ref>{{Cite web|date=2016-01-22|title=Fellow of the American Society of Clinical Oncology|url=https://www.asco.org/about-asco/awards-recognition/fellow-american-society-clinical-oncology|access-date=2021-08-24|website=ASCO|language=en}}</ref> She serves on a number of editorial review boards. including the [[Journal of Clinical Oncology]], as well as on the Scientific Advisory Board for the [[Breast Cancer Research Foundation]] and FORCE. |
|||
==References== |
==References== |
Latest revision as of 18:21, 21 July 2024
Susan M. Domchek is an oncologist at the University of Pennsylvania, Executive Director of the Basser Center for BRCA, the Basser Professor in Oncology at the Perelman School of Medicine, and Director of the Mariann and Robert MacDonald Cancer Risk Evaluation Program at Penn Medicine.[1][2] She has authored more than 250 articles in scholarly journals. In 2018, Domchek was elected to the National Academy of Medicine.
Career
[edit]In 2011, she led the organization of the international team of physician scientists known as BRCA-TAC, which led a charge to advance clinical testing of olaparib in cancer patients with known inherited mutations in BRCA1 and BRCA2.[3][1] Cancers that are associated with BRCA1 and BRCA2 include breast cancer in men and women, ovarian cancer, melanoma, prostate and pancreatic cancer.[4]
In 2012, Domchek was named Executive Director of the Basser Center for BRCA at Penn Medicine's Abramson Cancer Center.[5] In 2015, Domchek was awarded the William Osler Patient Oriented Research Award for her clinical research in breast cancer genetics.[6] In 2018, Domchek was elected to the National Academy of Medicine[7] and was honored with the 2018 Spirit of Empowerment by the non-profit organization Facing Our Risk of Cancer Empowered.[3]
References
[edit]- ^ a b Rabin, Roni Caryn (2018-03-06). "F.D.A. Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats". The New York Times. ISSN 0362-4331. Retrieved 2019-04-05.
- ^ "Home | Basser Center". www.basser.org. Retrieved 2021-08-24.
- ^ a b "FORCE Announces 2018 Spirit of Empowerment Awards Recipients" (PDF). Facing Our Risk of Cancer Empowered.
- ^ Mackin-Solomon, Ashley (2018-07-26). "Panel on BRCA genes in La Jolla explains cancer risks". lajollalight.com. Retrieved 2019-04-05.
- ^ "About the Basser Center | Basser Center". www.basser.org. Retrieved 2021-08-24.
- ^ "2015 Perelman School of Medicine Awards of Excellence". almanac.upenn.edu. November 17, 2015. Retrieved April 5, 2019.
- ^ "Four Penn Faculty Members Elected to National Academy of Medicine". pennmedicine.org. October 15, 2018. Retrieved April 5, 2019.